Resmed Inc. buy The Goldman Sachs Group, Inc.
Start price
16.01.25
/
50%
€228.00
Target price
16.01.26
-
Performance (%)
-2.81%
End price
17.01.26
€221.60
Summary
This prediction ended on 17.01.26 with a price of €221.60. With a performance of -2.81%, the BUY prediction by The_Goldman_Sachs_Gr finished with a loss. Dividends of €0.51 are taken into consideration when calculating the performance. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -0.874% | -0.874% | -11.358% |
| iShares Core DAX® | -1.410% | 0.471% | 12.651% |
| iShares Nasdaq 100 | -0.450% | -0.305% | 5.495% |
| iShares Nikkei 225® | -0.224% | 5.529% | 18.894% |
| iShares S&P 500 | -1.095% | -0.774% | 1.350% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten